Amino acid and protein oxidation in cardiovascular disease

Amino Acids

Volumn 25, Issue 3-4, 2003, Pages 365-374

  Brennan, M L ^a   Hazen, S L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Chlorination; Free Radical; Inflammation; Lipid peroxidation; Myeloperoxidase; Nitration

Indexed keywords

3 NITROTYROSINE; AMINO ACID; ANTIOXIDANT; FREE RADICAL; MOLECULAR MARKER; MYELOPEROXIDASE; PROTEIN; STATINE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHLORINATION; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; HUMAN; IN VITRO STUDY; INFLAMMATION; LIPID PEROXIDATION; NITRATION; NONHUMAN; OXIDATION; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

AMINO ACIDS; ANIMALS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; FREE RADICALS; HUMANS; OXIDATION-REDUCTION; PHAGOCYTES; PROTEINS; REACTIVE NITROGEN SPECIES; TYROSINE;

ANIMALIA;

EID: 0346731060     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-003-0023-y     Document Type: Review

References (103)

1. Agner K (1972) Structure and function of oxidation-reduction enzymes. In: Akeson A, Ehrenberg A (eds) Structure and function of oxidation-reduction enzymes. Pergamon Press, Inc. Tarrytown, NY, pp 329-335
2. Albrich JM, McCarthy CA, Hurst JK (1981) Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc Natl Acad Sci USA 78: 210-214
3. Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922
4. Anderson MM, Hazen SL, Hsu FF, Heinecke JW (1997) Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein: A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J Clin Invest 99: 424-432
5. Askari, AT, Brennan ML, Zhou X, Thomas JD, Topol EJ, Hazen SL, Penn MS (2003) Myeloperoxidase and plasminogen activator inhibitor-1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 197 (5): 615-624
6. Babior BM (1978) Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298: 659-663
7. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS (2001) p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108: 1423-1424
8. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624
9. Beckman JS, Chen J, Ischiropoulos H, Crow JP (1994a) Oxidative chemistry of peroxynitrite. Methods Enzymol 233: 229-240
10. Beckman JS, Ye YZ, Anderson P, Chen J, Accaretti MA, Tarpey MM, White CR (1994b) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375: 81-88
11. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis, AJ (1995) Atherosclerosis: Basic mechanisms, oxidation, inflammation and genetics. Circulation 91: 2488-2496
12. Brennan ML, Anderson M, Shih D, Qu X, Wang X, Mehta A, Lim L, Shi W, Hazen SL, Jacob J, Crowley J, Heinecke JW, Lusis AJ (2001) Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 107: 419-430
13. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HA, Ischiropoulos H, Hazen SL (2002) A tale of two controversies: i) Defining the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase deficient mice; and ii) Defining the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 277: 17415-17427
14. Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E (2001) Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 87: 636-639
15. Cardillo C, Kilcoyne CM, Cannon RO 3rd, Quyumi AA, Panza JA (1997) Xanthine oxidase Inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30: 57-63
16. Dabbagh AJ, Frei B (1995) Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophage and in cell-free systems. J Clin Invest 96: 1958-1966
17. Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 279: 1477-1482
18. Daugherty A, Dunn JL, Rateri DLm Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidants, is expressed in human atherosclerotic lesions. J Clin Invest 94: 437-444
19. Davies MJ, Fu S, Hongjie W, Dean RT (1999) Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med 27: 1151-1163
20. Diaz MN, Frei B, Vita JA, Keaney JF (1997) Antioxidants and atherosclerotic heart disease. N Engl J Med 337: 408-416
21. Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vleit A (1996) Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid: A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 271: 19199-19208
22. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397
23. Febbraio M, Podrez EA, Smith JD, Hazen SL, Hoff HF, Sharma K, Hajjar DP, Silverstein RL (2000) Targeted disruption of the class B scavenger receptor, CD36, protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056
24. Foote CS, Goyne TE, Lehrer RI (1983) Assessment of chlorination by human neutrophils. Nature 301: 715-716
25. Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK (2000) Ceruloplasmin and cardiovascular disease. Free Radic Biol Med 28: 1735-1744
26. Francis GA, Mendez AJ, Bierman EL, Heinecke JW (1993) Oxidative tyrosylation of high density lipoproteins by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc Natl Acad Sci USA 90: 6631-6634
27. Frost MT, Halliwell B, Moore KP (2000) Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J 345: 453-458
28. Fu S, Davies MJ, Stocker R, Dean RT (1998) Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem 333: 519-525
29. Fu X, Kassini SY, Parks WC, Heinecke JW (2001) Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276: 41279-41287
30. Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usmar V, Moncada S (1993) Peroxynitrite modification of low-density lipoproteins leads to recognition by the macrophage scavenger receptor. FEBS Lett 330: 181-185
31. Harrison JE, Schultz J (1976) Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251: 1371-1374
32. Hazen SL, Hsu FF, Duffin K, Heinecke JW (1996a) Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J Biol Chem 271: 23080-23088
33. Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW (1996b) Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 98: 1283-1289
34. Hazen SL, Hsu FF, Heinecke JW (1996c) p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes: A chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J Biol Chem 271: 1861-1867
35. Hazen SL, Heinecke JW (1997a) 3-Chlorotyrosine, a specific marker for myeloperoxidase-catalyzed halogenation, is present in human atherosclerotic aorta. J Clin Invest 99: 2075-2081
36. 2-Cl system of phagocytes, covalently modifies Nε-lysine residues of proteins. J Biol Chem 272: 169990-16998
37. - -system to oxidize α-amino acids to a family of reactive aldehydes: Mechanistic studies identifying labile intermediates along the reaction pathway. J Biol Chem 273: 4997-5005
38. Hazen SL, Hsu FF, d'Avignon A, Heinecke JW (1998b) Human neutrophils employ myeloperoxidase to convert α-amino acids to a battery of reactive aldehydes: A pathway for aldehyde formation at sites of inflammation. Biochemistry 37: 6864-6873
39. Hazen SL, Zhang R, Wu W, Podrez EA, Shen Z, MacPhearson J, Schmitt D, Mitra SN, Chen Y, Cohen P, Hoff HF, Abu-Soud HM (1999a) Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 85: 950-958
40. Hazen SL, Heller J, Hsu FF, d'Avignon A, Heinecke JW (1999b) Synthesis, isolation and characterization of the adduct formed in the reaction of p-hydroxyphenylacetaldehyde with the amino head group of phosphatidyl ethanolamine and phosphatidylserine. Chem Res Toxicol 12: 19-27
41. Hazen SL, Gaut JP, Crowley JR, Hsu FF, Heinecke JW (2000) Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions. Biochem J 352: 693-699
42. Heinecke JW, Li W, Francis GA, Goldstein JA (1993) Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking proteins. J Clin Invest 91: 2866-2872
43. Heinecke JW (2001) Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 21: 1261-1264
44. Heinecke JW (2002) Tyrosyl radical production by myelperoxidase: A phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology 177: 11-22
45. Heller JI, Crowley JR, Hazen SL, Salvay DM, Wagner P, Pennathur S, Heinecke JW (2000) p-Hydroxyphenylactaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J Biol Chem 275: 9957-9962
46. Hsu FF, Hazen SL, Giblin D, Turk J, Heinecke JW, Gross MK (1999) Mass spectrometric analysis of oxime derivatives of reactive biological aldehydes. Interntl J Mass Spec 186: 795-812
47. Hua C, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 87: 840-844
48. Huggins TG, Wells-Knecht MC, Detorie NA, Baynes JW, Thorpe SR (1993) Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation. J Biol Chem 268: 12341-12347
49. Jiang Q, Hurst JK (1997) Relative chlorinating, nitrating, and oxidizing capabilities of neutrophils determined with phagocytosable probes. J Biol Chem 272: 32767-32772
50. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA (1999) Superoxide anion production is increased in a model of genetic hypertension: Role of the endothelium. Hypertension 33: 1353-1358
51. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC (2000) Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 1529-1535
52. Klebanoff SJ (1980) Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 93: 480-489
53. Kutter D, Dvaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A (2000) Consequences of total and subtotal myeloperoxidase deficiency: Risk or benefit? Acta Haematol 104: 10-15
54. Lee SH, Oe T, Blair IA (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001 292: 2083-2086
55. Leeuewenburgh C, Hardy MM, Hazen SL, Wagner O, Oh-ishi S, Steinbrecher UP, Heineke JW (1997a) Reactive nitrogen intermediates promotes low density lipoproteins oxidation in human atherosclerotic intima. J Biol Chem 272: 1433-1436
56. Leewenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW (1997b) Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoproteins isolated from human atherosclerotic plaques. J Biol Chem 272: 3520-3526
57. Libby P (1995) Molecular basis of the acute coronary syndromes. Circulation 91: 2844-2850
58. MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk M, Hazen SL (2001) Eosinophils are a major source of NO-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunology 166: 5763-5772
59. Meagher EA, Barry OP, Lawson JA, Rokach J, FitzGerald GA (2001) Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285: 1178-1182
60. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M (1991) Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88: 10045-10048
61. Nauseef WM (2001) The proper study of mankind. J Clin Invest 107: 401-403
62. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M (1992) Leukocyte count correlates in middle-aged adults: The atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 136: 525-537
63. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA (2001) A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Amer Heart J 142: 336-339
64. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increase endothelial superoxide anion production. J Clin Invest 91: 2546-2551
65. Penn MS, Brennan ML, Sim JE, Heinecke JW, Spitz DR, Hazen SL (2003) Myeloperoxidase generates cytotoxic aldehydes as products of amino acid oxidation in vivo. (submitted)
66. Peppin GJ, Weiss SJ (1986) Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci USA 83: 4322-4326
67. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J (1998) Vitamin C exhibits pro-oxidant properties. Nature 392: 55
68. Podrez EA, Schmidt D, Hoff HF, Hazen SL (1999) Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103: 1547-1560
69. Podrez EA, Abu-Soud HM, Hazen SL (2000a) Myeloperoxidase-generated oxidants and atherosclerosis. Free Rad Biol Med 28: 1717-1725
70. Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein R, Hajjar DP, Cohen PA, Frazier WA, Hoff HF, Hazen SL (2000b) The macrophage scavenger receptor CD36 is the major receptor for LDL recognition following modification by monocyte-generated reactive nitrogen species. J Clin Invest 105: 1095-1108
71. Reynolds GD, Vance RP (1987) C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 111: 265-269
72. Ridker PM, Cushman M, Stampfer MJ Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979
73. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM (2001) Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959-1965
74. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809
75. Rubbo H, Radi R, Anselmi D, et al. (2000) Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate. J Biol Chem 275: 10812-10818
76. Shabani F, McNeil J, Tippett L (1998) The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCl) is suppressed by anti-rheumatic drug. Free Radic Res 28: 115-123
77. 2-imbalance in insulin-resistant rat aorta. Diabetes 48: 2437-2445
78. Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF, Penn MS, Sprecher DL, Vita JA, Hazen SL (2003) Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289: 1675-1680
79. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Taylor WR, Griendling KK (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435
80. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 87: 364-368
81. Stadtman ER (1992) Protein oxidation and aging. Science 257: 1220-1224
82. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 347: 781-786
83. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158: 879-891
84. Thomas CE (1992) The influence of medium components on Cu-dependent oxidation of low density lipoproteins and its sensitivity to superoxide dismutase. Biochim Biophys Acta 1128: 50-57
85. Thomas EL, Jefferson MM, Grisham MB (1982) Myeloperoxidase-catalyzed incorporation of amines into proteins: Role of hypochlorous acid and dichloramines. Biochemistry 21: 6299-6308
86. Thomas SR, Stocker R (2000) Molecular action of vitamin E in lipoprotein oxidation: Implication for atherosclerosis. Free Radic Biol Med 28: 1795-1805
87. Upston JM, Niu X, Brown AJ, Mashima R, Wang H, Senthilmohan R, Kettle AJ, Dean RT, Stocker R (2002a) Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 160: 701-710
88. Upston JM, Ternetis AC, Morris K, Keaney Jr JF, Stocker R (2002b) Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis. Biochem J 363: 753-760
89. van der Vleit A, Eiserich JP, Halliwell B, Cross CE (1997) Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 272: 7617-7625
90. Vlaicu R, Rus HG, Niculescu F, Cristea A (1985) Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 55: 35-50
91. Wang WQ, Merriam DL, Moses AS, Francis GA (1998) Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem 273: 17391-17398
92. Weil I, Morris JC (1949) Kinetic studies on the chloramines. I. The rates of formation of monochloramine, N-chlormethylamine and N-chlordimethylamine. J Am Chem Soc 71: 1664-1671
93. Weiss SJ, Klein R, Slivka A, Wei M (1982) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 70: 598-607
94. Weiss SJ, Test ST, Eckmann CM, Ross D, Regiania D (1986) Brominating oxidants generated by human eosinophils. Science 234: 200-203
95. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365-376
96. White GC (1972) Chemistry of chlorination. In White GC (ed) Handbook of chlorination. Van Nostrand Reinhold, New York, NY pp 182-227
97. Winterbourn CC, van den Berg JJ, Roitman E, Kuypers FA (1992) Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch Biochem Biophys 296: 547-555
98. Witztum JL, Steinberg D (2001) The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 11: 93-102
99. Wu W, Chen Y, Hazen SL (1999a) Eosinophil peroxidase nitrates protein tyrosyl residues. Implication for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274: 25933-25944
100. Wu W, d'Avignon A, Chen YH, Hazen SL (1999b) 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: Potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 38: 3538-3548
101. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce G, Penn MS, Topol EJ, Sprecher DS, Hazen SL (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286: 2136-2142
102. Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda C, Hazen SL (2002a) Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277: 46116-46122
103. Zhang R, Shen Z, Nauseef WM, Hazen SL (2002b) The role of myeloperoxidase in the initiation of lipid peroxidation in plasma as studied in neutrophils isolated from myeloperoxidase deficient subjects: Systematic approach to the identification and characterization of multiple diffusible endogenous substrates for myeloperoxidase in plasma. Blood 99: 1802-1810